Fatemeh Sadat Hosseini Khajouei: Can Repeat Thrombolysis Save Lives in Massive Pulmonary Embolism?
Fatemeh Sadat Hosseini Khajouei, Medical Student at Arak Medical University, shard on LinekdIn about a recent article she and her colleagues co-authored, published in Thrombosis Journal, adding:
”This is not just a publication; it may be one more step toward saving a life!
What should we do when guideline-supported treatment fails, but the patient is still fighting for life?
Our newly published case report describes a patient with massive pulmonary embolism who remained critically ill despite standard thrombolytic therapy.
With no access to catheter-directed therapy or surgical embolectomy, repeat systemic thrombolysis became the rescue strategy; and the patient recovered.
One case cannot change clinical practice, but it can contribute to the evidence that shapes future decisions.
We hope this report adds to the discussion on managing massive pulmonary embolism, particularly in resource-limited settings.
My deepest gratitude to Dr. Amir Hoseini, whose guidance, trust, and unwavering support have meant far more than mentorship.
I’m also sincerely thankful to my co-authors, especially Maede Aghahoseini for her invaluable collaboration throughout this work, and my hardworking colleague, Negar Azami.
Proud to see our work published in BMC Thrombosis Journal.
I would be delighted to hear your thoughts on this challenging clinical scenario.”
Title: Re-administration of thrombolytics in massive pulmonary embolism with initial therapy failure: a case report
Authors: Seyed amir Hoseini, Maede Aghahoseini, Mohammad javad Aminizadeh, Fatemeh Sadat Hosseini Khajouei, Negar Azami
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation